Schizophrenic patients show higher complexity values as compared to controls. Schizophrenic patients showed a tendency to reduced complexity values as a function of age while controls showed the opposite tendency The tendency observed in schizophrenic patients parallels the tendency observed in Alzheimer disease patients.
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Schizophrenic patients show higher complexity values as compared to controls. Schizophrenic patients showed a tendency to reduced complexity values as a function of age while controls showed the opposite tendency The tendency observed in schizophrenic patients parallels the tendency observed in Alzheimer disease patients.
a b s t r a c t
Objective: The neurodevelopmental-neurodegenerative debate is a basic issue in the field of the neuropathological basis of schizophrenia (SCH). Neurophysiological techniques have been scarcely involved in such debate, but nonlinear analysis methods may contribute to it. Methods: Fifteen patients (age range 23-42 years) matching DSM IV-TR criteria for SCH, and 15 sex-and age-matched control subjects (age range 23-42 years) underwent a resting-state magnetoencephalographic evaluation and Lempel-Ziv complexity (LZC) scores were calculated. Results: Regression analyses indicated that LZC values were strongly dependent on age. Complexity scores increased as a function of age in controls, while SCH patients exhibited a progressive reduction of LZC values. A logistic model including LZC scores, age and the interaction of both variables allowed the classification of patients and controls with high sensitivity and specificity. Conclusions: Results demonstrated that SCH patients failed to follow the ''normal'' process of complexity increase as a function of age. In addition, SCH patients exhibited a significant reduction of complexity scores as a function of age, thus paralleling the pattern observed in neurodegenerative diseases. Significance: Our results support the notion of a progressive defect in SCH, which does not contradict the existence of a basic neurodevelopmental alteration. Ó 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Schizophrenia (SCH) is a serious psychiatric disorder with a range of ''positive'' symptoms including paranoia, delusions and hallucinations, as well as ''negative'' symptoms such as cognitive impairment, flattened affect and disorganised thinking. Symptoms most commonly present in late adolesence in males and somewhat later in females, and the first psychotic episode is commonly preceded by a ''prodromal'' phase of progressively more severe symptoms which can last months or years.
Clinically, it is a common observation that a functional decline starts around the time of the late prodromal phase or around the first psychotic episode (Tully and McGlashan, 2006) , suggesting that a neurodegenerative process may be at the core of SCH. However, this neurodegenerative perspective has been challenged by the so-called neurodevelopmental theory (Murray and Lewis, 1987; Rapoport et al., 2005) which considers SCH as the product of a deviation in neurodevelopmental processes that occurs before the onset of clinical symptoms (Rapoport et al., 2005 
